Skip to main content
Premium Trial:

Request an Annual Quote

NCI Gives $13.4M for Two Proteomics Consortia to Create Standards, Resources for Cancer Biomarker Discovery

NEW YORK, Dec. 9 (GenomeWeb News) - Two proteomics research consortia led by the University of Michigan and the Fred Hutchinson Cancer Research Center have received grants totaling $13.4 million from the National Cancer Institute to develop standard tools and resources for protein biomarker discovery, NCI said yesterday.


Under the two-year awards, the researchers will use mouse models of human cancers to evaluate and develop proteomic techniques, and to create resources of biological samples and reagents for the research community. The aim is to create a technological platform for the discovery and clinical validation of protein biomarkers for cancer.


The research teams, led by former HUPO president Sam Hanash at the Universityof Michiganand by Martin McIntosh and Amanda Paulovich at the FredHutchinsonCancerResearchCenter, will collect and distribute their data through the cancer Biomedical Informatics Grid, caBIG.


The Universityof Michiganconsortium includes scientists from the HarvardPartnersCenterfor Genetics and Genomics, MIT, Dana Farber Cancer Institute, Van Andel Research Institute, and MemorialSloan-KetteringCancerCenter. The team led by the Hutchinson Centerincludes researchers from the Institute for Systems Biology, Pacific Northwest National Laboratory, and the Plasma Proteome Institute.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.